Combined treatment with tamoxifen and a fusicoccin derivative (ISIR-042) to overcome resistance to therapy and to enhance the antitumor activity of 5-fluorouracil and gemcitabine in pancreatic cancer cells

Takaaki Miyake(Shimane University), Junji Suzumiya(Koga Hospital), Takeshi Urano(Shimane University), Nobuo Kato(Kanazawa Medical University), Yoshio Honma(National Cancer Center Hospital East)
International Journal of Oncology
April 30, 2015
Cited by 22


Related Papers